References
- Rasmussen, T., Knudsen, L.M. and Johnsen, H.E. (2001) "Frequency and prognostic relevance of cyclin D1 dysregula-tion in multiple myeloma", Fur. J. Haematol. 67, 296–301.
- Hoechtlen-Vollmar, W., Menzel, G., Bartl, R., Lamerz, R., Wick, M. and Seidel, D. (2000) "Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance", Br. J. Haematol. 109, 30–38.
- Soverini, S., Cavo, M., Cellini, C., Terragna, C., Zamagni, E., Ruggeri, D., Testoni, N., Tosi, P., de Vivo, A., Amabile, M., Grafone, T., Ottaviani, E., Giannini, B., Cangini, D., Bonifazi, F., Neri, A., Fabris, S., Tura, S., Baccarani, M. and Martinelli, G. (2003) "Cyclin D1 overexpressin is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation", Blood 102, 1588–1594.